These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38825515)

  • 1. [Epigenetic dysregulation and emerging treatment strategies in myelodysplastic syndromes].
    Kunimoto H
    Rinsho Ketsueki; 2024; 65(5):362-374. PubMed ID: 38825515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics of myelodysplastic syndromes.
    Itzykson R; Fenaux P
    Leukemia; 2014 Mar; 28(3):497-506. PubMed ID: 24247656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes.
    Khan H; Vale C; Bhagat T; Verma A
    Semin Hematol; 2013 Jan; 50(1):16-37. PubMed ID: 23507481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents.
    Santini V; Melnick A; Maciejewski JP; Duprez E; Nervi C; Cocco L; Ford KG; Mufti G
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):231-45. PubMed ID: 23838480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.
    Vasilatou D; Papageorgiou SG; Dimitriadis G; Pappa V
    Epigenetics; 2013 Jun; 8(6):561-70. PubMed ID: 23760524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in myelodysplastic syndromes.
    Heuser M; Yun H; Thol F
    Semin Cancer Biol; 2018 Aug; 51():170-179. PubMed ID: 28778402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional mechanisms of mutations in myelodysplastic syndrome.
    Nagata Y; Maciejewski JP
    Leukemia; 2019 Dec; 33(12):2779-2794. PubMed ID: 31673113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic changes in the myelodysplastic syndrome.
    Issa JP
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):317-30. PubMed ID: 20359628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone methylation in myelodysplastic syndromes.
    Wei Y; Gañán-Gómez I; Salazar-Dimicoli S; McCay SL; Garcia-Manero G
    Epigenomics; 2011 Apr; 3(2):193-205. PubMed ID: 22122281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
    Nakajima H
    Intern Med; 2021 Jan; 60(1):15-23. PubMed ID: 32009100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic dysregulation in myelodysplastic syndromes].
    Sashida G
    Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
    Jhanwar SC
    Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?
    Chung SS
    Curr Opin Hematol; 2016 Mar; 23(2):79-87. PubMed ID: 26825694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of histone methyltransferase EZH2 in myelodysplastic syndromes.
    Xu F; Li X
    Expert Rev Hematol; 2012 Apr; 5(2):177-85. PubMed ID: 22475286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome.
    Hasegawa N; Oshima M; Sashida G; Matsui H; Koide S; Saraya A; Wang C; Muto T; Takane K; Kaneda A; Shimoda K; Nakaseko C; Yokote K; Iwama A
    Leukemia; 2017 Apr; 31(4):861-871. PubMed ID: 27694924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenetic alterations in myelodysplastic syndromes].
    Xu F; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):531-5. PubMed ID: 20416204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in epigenetic regulators in myelodysplastic syndromes.
    Nikoloski G; van der Reijden BA; Jansen JH
    Int J Hematol; 2012 Jan; 95(1):8-16. PubMed ID: 22234528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathogenesis of the myelodysplastic syndromes.
    Pellagatti A; Boultwood J
    Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes.
    Itzykson R; Kosmider O; Fenaux P
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):355-64. PubMed ID: 24507812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.